Sign In
OZYMF.US
id: 735

Orphazyme A/S (ORPH) $2.5M IPO Settlement

It is still possible to file a late claim. The court will decide whether to accept late claims or not.
N.D. Illinois
Court
1:21-CV-03640
Case number
29 Sept 2020
Class period Start
04 Nov 2021
Class period End
17 Jan 2024
Claim deadline
Orphazyme A/S (ORPH) agreed to settle $2.5 million with investors to end claims over misleading statements during its IPO in 2020.
Case Status
Accepting Late Claims
Alleged Offence
Misleading Statements
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Depository Securities (ADS, ADR, GDR)
Trade Direction
Long
Payout per Share
0.12
Filing date
09 July 2021
Plaintiffs
Marko Busic
Attorneys
Bronstein, Gewirtz & Grossman, LLC (New York, NY), Pomerantz LLP (Chicago, IL)
Defendants
Christophe Bourdon, Anders Vadsholt, Kim Stratton, Thomas Blaettler, Molly Painter, Georges Gemayel, Bo Jesper Hansen, Martin Bonde, Rémi Droller, Sten Verland, Martijn Kleijwegt, Anders Hedegaard, Catherine Moukheibir, Carrolee Barlow
Judge
Hon. John F. Kness
Administrator
A.B. Data Ltd
Settlement agreement date
2023-05-12
Trades matching type
FIFO
+$2,500,000
Cash Settlement Amount